This investment thesis report delves into the booming market of fertility care, emphasizing the increasing rates of infertility particularly in the United States. It explores the lifestyle and environmental causes of infertility and highlights the challenges faced by couples seeking fertility treatments, with a focus on the prohibitive costs associated with in vitro fertilization (IVF). The paper subsequently discusses the disparities in insurance coverage for fertility treatments across states and employers, the recent consolidation of fertility clinics, and the largely overlooked issue of male factor infertility. Contextual factors, such as the impact of the COVID-19 pandemic, the rise in individuals identifying as LGBTQ+, and the legal implications of the Dobbs Supreme Court ruling, are also considered. Finally, the report touches on investment areas and opportunities in the fertility market, underscoring the need for innovation, inclusivity, and proactive approaches to reproductive care.
Read MoreCredo Health, a leader in technology for value-based care, has successfully secured $5.25 million in series seed funding. FCA Venture Partners led the round with existing investors that include Hannah Grey VC, FirstMile Ventures, and SpringTime Ventures.
Read MoreNashville, known for its country music and Southern charm, is also home to a booming health-tech startup scene. The city has a rich history with health care that experts say makes it uniquely suited for innovation in the industry. CNBC spoke with a dozen founders, investors and executives in Nashville who described a tight-knit, supportive community that’s growing larger by the day.
Read MorePayGround, a healthcare fintech payments platform, today announced closing a $19.7M oversubscribed Series A financing led by SixThirty with participation from Rally Ventures, IA Capital Group, FCA Venture Partners and Plug and Play Ventures. The funding will bolster the company's rapid expansion into hospitals and health systems, building on its success in the ambulatory market, as well as grow its senior leadership team.
Read MoreClinical trial sites are exploring new technology innovations to simplify and fix the many challenges faced by clinical trials today. Advanced technology for clinical trials would lead to many benefits, including faster recruitment, higher patient retention rates due to improved patient experience, advanced data collection, and virtual patient observation. Perhaps the most valuable benefit from advancing technology, however, is the implementation of decentralized clinical trials, clinical trials executed through telemedicine and technology different from the traditional clinical trial model.
Read MoreThe increasing attention of AI in corporate communications and rising public interest make clear that AI in healthcare is not just a transient trend but a necessity for a more efficient, personalized, and accessible future. As AI becomes integrated into more healthcare processes, it is critical to maintain a focus on patient safety by creating regulatory policies to maintain integrity and ensure accurate data.
Read MoreSafeRide Health, the leading technology-first platform connecting patients to life sustaining care, announced today the close of their Series B. SafeRide’s Series B is led by Sands Capital, a global asset manager with over $80 billion under management, with additional participation from new investors Seminal Capital, Hill City Capital, Fry’s Path Capital and Primetime Partners, as well as existing investors Fresenius Medical Ventures, Bonfire Ventures and Meridian Street Capital.
Read More